Joshua Brody, Associate Professor, Division of Hematology and Oncology at Icahn School of Medicine at Mount Sinai, shared on LinkedIn:
“ASH25 update on Follicular Lymphoma immunotherapies esp Bispecific Antibodies featuring the Lady and the Tramp bit that (I think) I stole from Dr. Matt Lunning.
More posts about ASH25.